Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04383496 · ClinicalTrials.gov registry record · Phase 1

Increasing Activity for Veterans With PTSD

A Phase 1 study, sponsored by VA Office of Research and Development.

Completed
Registry status
Phase 1
Development phase
24
Enrollment target

NCT04383496: Completed Phase 1 study, sponsored by VA Office of Research and Development.

NCT04383496 is a Phase 1 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 24 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04383496, a Phase 1 study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
Phase 1
Development phase
24 participants
Enrollment target

Study Summary

The proposed work will be a key step forward in fulfilling the mission of VA RR\&D to restore function and enable social reintegration for Veterans. Development of an intervention to increase physical activity may improve physical functioning for Veterans with posttraumatic stress disorder (PTSD), thus addressing an important gap in existing care. If demonstrated to be efficacious in a future randomized trial, this intervention could be implemented throughout VHA to improve quality of life and enable a full recovery for many Veterans with PTSD. Results from the proposed work may also advance our understanding of how to optimally incorporate mobile health technology (mHealth) with more traditional types of patient contacts, such as in-person visits and telephone calls. Effective use of mHealth may offer greater flexibility for VHA clinics looking to implement new programs. Incorporation of mHealth may also increase access to clinical services for Veterans who reside far from VHA facilities.

Primary Outcome

total participants enrolled in intervention (out of total patients identified as eligible)

Interventions

  • BEHAVIORAL Physical Activity

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2021-03-02
Est. Completion 2022-06-28
Phase Phase 1
VA Office of Research and Development

1,668 total trials

What the finished NCT04383496 record still lists

NCT04383496 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% lower).

The record links to 0 conditions, and to 1 intervention - of which Physical Activity is the first listed.

NCT04383496 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04383496 about?

NCT04383496 is a clinical study titled "Increasing Activity for Veterans With PTSD". The proposed work will be a key step forward in fulfilling the mission of VA RR\&D to restore function and enable social reintegration for Veterans. Development of an intervention to increase physical activity may improve physical functioning for Veterans with posttraumatic stress disorder (PTSD), t...

What is the current status of trial NCT04383496?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2021-03-02. Estimated completion is 2022-06-28.

What interventions are being tested in trial NCT04383496?

The interventions under investigation include: Physical Activity (BEHAVIORAL).

Who is sponsoring clinical trial NCT04383496?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04383496's enrollment target sits among peer trials

24 1520th of 2000 higher than 405 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04383496, the US trial registry maintained by the National Library of Medicine. NCT04383496 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.